Sharda Crop
Anand Rathi
Broker Research reports
for Industry - Agrochemicals
- This broker has downgraded this stock from it's previous report. (eg. - Buy->Hold)
- Broker has maintained previous recommendation but reduced share price target.
- This broker has upgraded this stock from it's previous report.(eg. - Sell->Hold)
- Broker has maintained previous recommendation but increased share price target.
RESEARCH REPORTS ALERTS
Load latest
Google or static link led you to an intermediate page.
- All Recent
- Upside
- Buy
- Sell
- Recent Upgrades
- Recent Downgrades
- IPO
- Sector Updates
- Most Recent
- Top Upside
Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.
| Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 16 May 2022 | Sharda Cropchem |
Anand Rathi
|
876.35 | 835.00 | 707.60 (23.85%) |
Buy
|
|||||
| 12 May 2022 | UPL |
Emkay
|
682.80 | 930.00 | 821.10 (-16.84%) | Pre-Bonus/ Split |
Buy
|
||||
| 10 May 2022 | UPL |
SMC online
|
682.80 | 781.55 (-12.64%) | Pre-Bonus/ Split |
Results Update
|
|||||
| 10 May 2022 | UPL |
Chola Wealth Direct
|
682.80 | 1050.00 | 792.15 (-13.80%) | Pre-Bonus/ Split |
Buy
|
||||
| 10 May 2022 | UPL |
ICICI Securities Limited
|
682.80 | 852.00 | 777.60 (-12.19%) | Pre-Bonus/ Split |
Accumulate
|
Healthy performance; Strong guidance
ICICI Securities Limited
Takeaways from Q4FY22: (1) Strong volume growth and market share gains resulted in higher YoY growth of international business; India business grew 62.6% YoY, (2) gross and EBITDA margin were up 369bps and 78bps YoY, respectively, and (3) Europe business grew only 2% YoY due to adverse impact
from Russia-Ukraine conflict. |
|||
| 10 May 2022 | UPL |
Prabhudas Lilladhar
|
682.80 | 1010.00 | 792.15 (-13.80%) | Pre-Bonus/ Split |
Buy
|
||||
| 09 May 2022 | UPL |
Motilal Oswal
|
682.80 | 880.00 | 789.80 (-13.55%) | Pre-Bonus/ Split |
Neutral
|
||||
| 04 May 2022 | Astec Lifesciences |
ICICI Direct
|
850.20 | 2215.00 | 1852.40 (-54.10%) | Target met |
Buy
|
||||
| 02 May 2022 | Sumitomo Chemical |
Ashika Research
|
582.20 | 500.00 | 437.45 (33.09%) | Target met |
Buy
|
||||
| 25 Apr 2022 | Rallis |
Anand Rathi
|
327.35 | 320.00 | 234.50 (39.59%) |
Buy
|
|||||
|
more
loading
|
|||||||||||
* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.